The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts
Clinically, many candidates for islet transplantation are already immunized, which increases their risk of graft rejection. Encapsulation of pancreatic islets using the TheraCyte™ device has been shown to protect against allograft rejection in nonimmunized recipients. However, the capacity of the Th...
Main Authors: | Makiko Kumagai-Braesch, Stella Jacobson, Hiroki Mori, Xiaohui Jia, Tohru Takahashi, Annika Wernerson, Malin Flodström-Tullberg, Annika Tibell |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-07-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X657486 |
Similar Items
-
Longitudinal Studies on the Microcirculation around the TheraCyte™ Immunoisolation Device, Using the Laser Doppler Technique
by: E. Rafael, et al.
Published: (2000-01-01) -
Continuous and High-Level in Vivo Delivery of Endostatin from Recombinant Cells Encapsulated in TheraCyte® Immunoisolation Devices
by: N. V. Malavasi, et al.
Published: (2010-03-01) -
Pancreatic Tissue Transplanted in TheraCyte Encapsulation Devices Is Protected and Prevents Hyperglycemia in a Mouse Model of Immune-Mediated Diabetes
by: Tobias Boettler, et al.
Published: (2016-03-01) -
Exendin-4 Increases the Expression of Hypoxia-Inducible Factor-1α in Rat Islets and Preserves the Endocrine Cell Volume of Both Free and Macroencapsulated Islet Grafts
by: Xiaohui Jia, et al.
Published: (2012-06-01) -
Effect of Fusidic Acid on Pancreatic Islet Allograft Rejection
by: Josá F. Mendola, et al.
Published: (1997-01-01)